David Abrams will be leaving Teva Pharmaceutical in the first quarter of 2024 as part of strategic portfolio adjustments.
Explore the stock picks of Seth Klarman and David Abrams by downloading their GuruFolio reports, updated on 05/13/2024.
XLV Health Care
Tuesday’s option activity is notable for EWCZ, SAVA, and DHR.
Notable options trading volume was observed today in European Wax Center Inc (EWCZ) within the Russell 3000 index, with a total of 2,290 contracts traded.
Tuesday’s option activity is notable for EWCZ, SAVA, and DHR. Read More »
BrainStorm Cell Therapeutics has released their financial results for the first quarter of 2024 and also given an update on the company’s operations.
BrainStorm Cell Therapeutics reports its financial results for the first quarter of 2024 and gives a corporate update.
XLV Healthcare SPDR – May Outlook
The patient remain unwell and in the market for better medicine.
XLV Healthcare SPDR – May Outlook Read More »